Lehmann F - Search Results

1

Breast cancer resistance protein and P-glycoprotein expression in patients with newly diagnosed and therapy-refractory ulcerative colitis compared with healthy controls.

Gutmann H, Hruz P, Zimmermann C, Straumann A, Terracciano L, Hammann F, Lehmann F, Beglinger C, Drewe J. Gutmann H, et al. Among authors: lehmann f. Digestion. 2008;78(2-3):154-62. doi: 10.1159/000179361. Epub 2008 Dec 3. Digestion. 2008. PMID: 19052456

2

Decreased expression of breast cancer resistance protein in the duodenum in patients with obstructive cholestasis.

Zimmermann C, Hruz P, Gutmann H, Terracciano L, Beuers U, Lehmann F, Beglinger C, Drewe J. Zimmermann C, et al. Among authors: lehmann f. Digestion. 2006;74(2):101-8. doi: 10.1159/000097800. Epub 2006 Dec 7. Digestion. 2006. PMID: 17159348

3

Current role of Helicobacter pylori stool tests.

Lehmann FS, Beglinger C. Lehmann FS, et al. Digestion. 2003;68(2-3):119-23. doi: 10.1159/000074682. Epub 2003 Nov 7. Digestion. 2003. PMID: 14610344 Review.

4

Monitoring of therapy for inflammatory bowel disease.

Burri E, Beglinger C, Lehmann FS. Burri E, et al. Digestion. 2012;86 Suppl 1:1-5. doi: 10.1159/000341953. Epub 2012 Oct 5. Digestion. 2012. PMID: 23051719 Review.

5

Helicobacter pylori and gastric erosions. Results of a prevalence study in asymptomatic volunteers.

Lehmann FS, Renner EL, Meyer-Wyss B, Wilder-Smith CH, Mazzucchelli L, Ruchti C, Drewe J, Beglinger C, Merki HS. Lehmann FS, et al. Digestion. 2000;62(2-3):82-6. doi: 10.1159/000007799. Digestion. 2000. PMID: 11025354

6

Role of pantoprazole in the treatment of gastro-oesophageal reflux disease.

Lehmann FS, Beglinger C. Lehmann FS, et al. Expert Opin Pharmacother. 2005 Jan;6(1):93-104. doi: 10.1517/14656566.6.1.93. Expert Opin Pharmacother. 2005. PMID: 15709887 Review.

7

Impact of COX-2 inhibitors in common clinical practice a gastroenterologist's perspective.

Lehmann FS, Beglinger C. Lehmann FS, et al. Curr Top Med Chem. 2005;5(5):449-64. doi: 10.2174/1568026054201703. Curr Top Med Chem. 2005. PMID: 15974940 Review.

8

Effect of ornidazole and clarithromycin resistance on eradication of Helicobacter pylori in peptic ulcer disease.

Lehmann FS, Drewe J, Terracciano L, Beglinger C. Lehmann FS, et al. Aliment Pharmacol Ther. 2000 Mar;14(3):305-9. doi: 10.1046/j.1365-2036.2000.00717.x. Aliment Pharmacol Ther. 2000. PMID: 10735923 Clinical Trial.

9

The role and utility of faecal markers in inflammatory bowel disease.

Lehmann FS, Burri E, Beglinger C. Lehmann FS, et al. Therap Adv Gastroenterol. 2015 Jan;8(1):23-36. doi: 10.1177/1756283X14553384. Therap Adv Gastroenterol. 2015. PMID: 25553077 Free PMC article. Review.

10

New molecular targets for treatment of peptic ulcer disease.

Lehmann F, Hildebrand P, Beglinger C. Lehmann F, et al. Drugs. 2003;63(17):1785-97. doi: 10.2165/00003495-200363170-00002. Drugs. 2003. PMID: 12921485 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

647 results

Search Page

Filters